Microbiota and the Response to Vaccines Against Respiratory Virus

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 May 23

PMID 35603203

Authors

Joao I B Goncalves

Thiago J Borges

Ana Paula Duarte de Souza

Affiliations

Soon will be listed here.

Abstract

This mini review describes the role of gut and lung microbiota during respiratory viral infection and discusses the implication of the microbiota composition on the immune responses generated by the vaccines designed to protect against these pathogens. This is a growing field and recent evidence supports that the composition and function of the microbiota can modulate the immune response of vaccination against respiratory viruses such as influenza and SARS-CoV-2. Recent studies have highlighted that molecules derived from the microbiome can have systemic effects, acting in distant organs. These molecules are recognized by the immune cells from the host and can trigger or modulate different responses, interfering with vaccination protection. Modulating the microbiota composition has been suggested as an approach to achieving more efficient protective immune responses. Studies in humans have reported associations between a better vaccine response and specific bacterial taxa. These associations vary among different vaccine strategies and are likely to be context-dependent. The use of prebiotics and probiotics in conjunction with vaccination demonstrated that bacterial components could act as adjuvants. Future microbiota-based interventions may potentially improve and optimize the responses of respiratory virus vaccines.

Citing Articles

Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during COVID-19 and other viral infections.

Kaushal A J Transl Med. 2024; 22(1):847.

PMID: 39294611 PMC: 11409805. DOI: 10.1186/s12967-024-05587-9.

IL-10 inhibition during immunization improves vaccine-induced protection against Staphylococcus aureus infection.

Kelly A, McCarthy K, Claxton T, Carlile S, OBrien E, Vozza E JCI Insight. 2024; 9(13).

PMID: 38973612 PMC: 11383370. DOI: 10.1172/jci.insight.178216.

Alterations in microbiota of patients with COVID-19: implications for therapeutic interventions.

Qiu Y, Mo C, Chen L, Ye W, Chen G, Zhu T MedComm (2020). 2024; 5(4):e513.

PMID: 38495122 PMC: 10943180. DOI: 10.1002/mco2.513.

Factors Influencing Microbiota in Modulating Vaccine Immune Response: A Long Way to Go.

Ponziani F, Coppola G, Rio P, Caldarelli M, Borriello R, Gambassi G Vaccines (Basel). 2023; 11(10).

PMID: 37897011 PMC: 10611107. DOI: 10.3390/vaccines11101609.

A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines.

Hong M, Lan T, Li Q, Li B, Yuan Y, Xu F Gut Microbes. 2023; 15(1):2233146.

PMID: 37431857 PMC: 10337507. DOI: 10.1080/19490976.2023.2233146.

References

Skelly A, Sato Y, Kearney S, Honda K . Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol. 2019; 19(5):305-323. DOI: 10.1038/s41577-019-0144-5. View

Groves H, Higham S, Moffatt M, Cox M, Tregoning J . Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence. mBio. 2020; 11(1). PMC: 7029140. DOI: 10.1128/mBio.03236-19. View

Ruff W, Greiling T, Kriegel M . Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol. 2020; 18(9):521-538. DOI: 10.1038/s41579-020-0367-2. View

Bassis C, Erb-Downward J, Dickson R, Freeman C, Schmidt T, Young V . Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio. 2015; 6(2):e00037. PMC: 4358017. DOI: 10.1128/mBio.00037-15. View

Tao W, Zhang G, Wang X, Guo M, Zeng W, Xu Z . Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18. Med Microecol. 2021; 5:100023. PMC: 7832617. DOI: 10.1016/j.medmic.2020.100023. View

Zaman K, Dang D, Victor J, Shin S, Yunus M, Dallas M . Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010; 376(9741):615-23. DOI: 10.1016/S0140-6736(10)60755-6. View

Machado M, Patente T, Rouille Y, Heumel S, Melo E, Deruyter L . Acetate Improves the Killing of by Alveolar Macrophages NLRP3 Inflammasome and Glycolysis-HIF-1α Axis. Front Immunol. 2022; 13:773261. PMC: 8810543. DOI: 10.3389/fimmu.2022.773261. View

Mathieu E, Escribano-Vazquez U, Descamps D, Cherbuy C, Langella P, Riffault S . Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma. Front Physiol. 2018; 9:1168. PMC: 6110890. DOI: 10.3389/fphys.2018.01168. View

Kurupati R, Kossenkov A, Haut L, Kannan S, Xiang Z, Li Y . Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood. Oncotarget. 2016; 7(39):62898-62911. PMC: 5325335. DOI: 10.18632/oncotarget.11704. View

10.

Maruyama M, Abe R, Shimono T, Iwabuchi N, Abe F, Xiao J . The effects of non-viable Lactobacillus on immune function in the elderly: a randomised, double-blind, placebo-controlled study. Int J Food Sci Nutr. 2015; 67(1):67-73. DOI: 10.3109/09637486.2015.1126564. View

11.

Tan J, McKenzie C, Potamitis M, Thorburn A, Mackay C, Macia L . The role of short-chain fatty acids in health and disease. Adv Immunol. 2014; 121:91-119. DOI: 10.1016/B978-0-12-800100-4.00003-9. View

12.

Chen L, Chen P, Hsu C . Commensal microflora contribute to host defense against Escherichia coli pneumonia through Toll-like receptors. Shock. 2011; 36(1):67-75. DOI: 10.1097/SHK.0b013e3182184ee7. View

13.

Chang P, Hao L, Offermanns S, Medzhitov R . The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014; 111(6):2247-52. PMC: 3926023. DOI: 10.1073/pnas.1322269111. View

14.

Dilantika C, Sedyaningsih E, Kasper M, Agtini M, Listiyaningsih E, Uyeki T . Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness. BMC Infect Dis. 2010; 10:3. PMC: 2820480. DOI: 10.1186/1471-2334-10-3. View

15.

Hagan T, Cortese M, Rouphael N, Boudreau C, Linde C, Maddur M . Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans. Cell. 2019; 178(6):1313-1328.e13. PMC: 6750738. DOI: 10.1016/j.cell.2019.08.010. View

16.

Yeh T, Shih P, Liu S, Lin C, Liu J, Lei W . The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2018; 12:217-230. PMC: 5790137. DOI: 10.2147/DDDT.S155110. View

17.

Rooks M, Garrett W . Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016; 16(6):341-52. PMC: 5541232. DOI: 10.1038/nri.2016.42. View

18.

Kim C . Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids. Cell Mol Immunol. 2021; 18(5):1161-1171. PMC: 8093302. DOI: 10.1038/s41423-020-00625-0. View

19.

Lavelle A, Sokol H . Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020; 17(4):223-237. DOI: 10.1038/s41575-019-0258-z. View

20.

Tanaka M, Nakayama J . Development of the gut microbiota in infancy and its impact on health in later life. Allergol Int. 2017; 66(4):515-522. DOI: 10.1016/j.alit.2017.07.010. View